Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rang în acțiuni #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Preț acțiune
$0.39
Capitalizare de piață
$13.79M
Schimbare (1 zi)
-13.53%
Schimbare (1 an)
-68.80%
Țară
IL
Tranzacționează NeuroSense Therapeutics Ltd. (NRSN)

Categorie

Istoric al prețului acțiunii pentru NeuroSense Therapeutics Ltd. (NRSN)
Cel mai mare preț de închidere: $0.47 pe 2026-08-01

Cel mai mic preț de închidere: $3.04 pe 2021-12-01
Istoric al prețului acțiunii pentru NeuroSense Therapeutics Ltd. din 2021 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE